Durect Corp (DRRX)

Apr 21, 2025

DURECT Co. (NASDAQ:DRRX) Sees Large Decline in Short Interest - Defense World

Apr 21, 2025

Apr 12, 2025

StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX) - Defense World

Apr 12, 2025

Apr 09, 2025

Durect Corp stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada

Apr 09, 2025

Apr 04, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated at StockNews.com - Defense World

Apr 04, 2025

Mar 31, 2025

DURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call Transcript - MSN

Mar 31, 2025

Mar 28, 2025

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation - Yahoo Finance

Mar 28, 2025

Mar 27, 2025

DURECT Corporation’s Earnings Call Highlights Cost Cuts and Breakthrough Potential - TipRanks

Mar 27, 2025

Mar 27, 2025

Durect Corp Q4 2024 Earnings: EPS of $0.25 Surpasses Estimates, Revenue Falls Short at $0.5 Million - GuruFocus

Mar 27, 2025

Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges - Yahoo Finance

Mar 27, 2025

Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic F - GuruFocus.com

Mar 27, 2025

Mar 26, 2025

Durect: Q4 Earnings Snapshot - MySA

Mar 26, 2025

Mar 26, 2025

Durect reports Q4 cont ops EPS (6c), consensus (2c) - TipRanks

Mar 26, 2025

Mar 26, 2025

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 26, 2025

Mar 26, 2025

Earnings call transcript: Durect’s Q4 2024 revenue drops as focus shifts to key drug - Investing.com India

Mar 26, 2025

Mar 26, 2025

DURECT Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 26, 2025

DURECT Transforms Business: $17.5M Asset Sale, NEJM Evidence Validates Key Drug Program - Stock Titan

Mar 26, 2025

Mar 26, 2025

Earnings Scheduled For March 26, 2025 - Benzinga

Mar 26, 2025

Mar 25, 2025

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings - GuruFocus

Mar 25, 2025

Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 - GuruFocus.com

Mar 19, 2025

Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - Quantisnow

Mar 19, 2025

Mar 19, 2025

DURECT (DRRX) to Release Quarterly Earnings on Wednesday - Defense World

Mar 19, 2025

Mar 19, 2025

StockNews.com Begins Coverage on DURECT (NASDAQ:DRRX) - Defense World

Mar 19, 2025

Mar 15, 2025

DURECT Corporation (NASDAQ:DRRX) Is Expected To Breakeven In The Near Future - Simply Wall St

Mar 15, 2025

Mar 07, 2025

Wnt efforts condensing at Dewpoint, Surrozen, more - BioWorld Online

Mar 07, 2025

Mar 06, 2025

Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial - Healio

Mar 06, 2025

Mar 03, 2025

DURECT (NASDAQ:DRRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 03, 2025

Feb 26, 2025

The R&D Dept.: Local patent roundup for 2.26.25 - RichmondBizSense

Feb 26, 2025

Feb 10, 2025

DURECT (NASDAQ:DRRX) Research Coverage Started at StockNews.com - Defense World

Feb 10, 2025

Feb 04, 2025

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Yahoo Finance

Feb 04, 2025

Feb 04, 2025

Exclusive Healthcare Conference Alert: DURECT CEO Reveals Latest Developments - Stock Titan

Feb 04, 2025

Jan 28, 2025

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - Stockhouse Publishing

Jan 28, 2025

Jan 22, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 22, 2025

Jan 16, 2025

Durect (DRRX) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Jan 16, 2025

Jan 13, 2025

Geode Capital Management LLC Has $429,000 Holdings in DURECT Co. (NASDAQ:DRRX) - Defense World

Jan 13, 2025

Jan 11, 2025

DURECT faces Nasdaq delisting over share price - Investing.com

Jan 11, 2025

Jan 09, 2025

New Strong Buy Stocks for January 9th - Yahoo Finance

Jan 09, 2025

Dec 27, 2024

Reviewing Acerus Pharmaceuticals (OTCMKTS:TRLPF) and DURECT (NASDAQ:DRRX) - Defense World

Dec 27, 2024

Dec 16, 2024

Microbial Products Market Size to Hit USD 351.42 Bn by 2034 - Precedence Research

Dec 16, 2024

Dec 11, 2024

Durect (DRRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Dec 11, 2024

Dec 02, 2024

DURECT Corp expected to post a loss of 17 cents a shareEarnings Preview - XM

Dec 02, 2024

Nov 28, 2024

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Nov 28, 2024

Nov 26, 2024

DURECT Corp sells ALZET product line to Lafayette - TradingPedia

Nov 26, 2024